financetom
Business
financetom
/
Business
/
Bkv Insider Sold Shares Worth $430,965, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Bkv Insider Sold Shares Worth $430,965, According to a Recent SEC Filing
May 26, 2025 7:58 AM

01:03 PM EDT, 05/14/2025 (MT Newswires) -- Ethan Ngo, Chief Corporate Development Officer, on May 13, 2025, sold 19,582 shares in Bkv (BKV) for $430,965. Following the Form 4 filing with the SEC, Ngo has control over a total of 244,759 common shares of the company, with 244,759 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1838406/000162828025025388/xslF345X05/wk-form4_1747241235.xml

Price: 22.48, Change: +0.10, Percent Change: +0.42

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Market Chatter: Banco Bilbao Vizcaya Shareholder GQG Partners Sells Stake Over Banco Sabadell Bid
Market Chatter: Banco Bilbao Vizcaya Shareholder GQG Partners Sells Stake Over Banco Sabadell Bid
Oct 21, 2024
07:57 AM EDT, 10/21/2024 (MT Newswires) -- Banco Bilbao Vizcaya Argentaria ( BBVA ) shareholder GQG Partners sold its stake in the bank as it opposed BBVA's hostile takeover bid for rival Banco Sabadell, the Financial Times reported Sunday, citing unnamed sources familiar with the matter. The report said GQG Partners was among the top five BBVA shareholders but no...
Top Premarket Gainers
Top Premarket Gainers
Oct 21, 2024
07:51 AM EDT, 10/21/2024 (MT Newswires) -- GRI Bio ( GRI ) shares increased more than three-fold pre-bell Monday following a 19% increase in the previous session. Siyata Mobile ( SYTA ) shares surged 132% after the company said that T-Mobile (TMUS) will start offering the company's mission-critical push-to-talk 5G cellular radio handsets. BioVie ( BIVI ) shares rose 52%...
AbbVie Unit Says US FDA Approves Botox Cosmetic as Treatment for Adults With Moderate to Severe Platysma Bands
AbbVie Unit Says US FDA Approves Botox Cosmetic as Treatment for Adults With Moderate to Severe Platysma Bands
Oct 21, 2024
07:57 AM EDT, 10/21/2024 (MT Newswires) -- AbbVie's ( ABBV ) Allergan Aesthetics unit said Monday the US Food and Drug Administration has approved its Botox Cosmetic brand of onabotulinumtoxinA to treat adult patients with moderate to severe platysma bands. Platysma bands connect the jaw and neck, and the cosmetic treatment is intended to improve the appearance of moderate to...
Gilead Sciences, Merck Say Phase 2 Study for HIV Treatment Combination Meets New Endpoints
Gilead Sciences, Merck Say Phase 2 Study for HIV Treatment Combination Meets New Endpoints
Oct 21, 2024
07:56 AM EDT, 10/21/2024 (MT Newswires) -- Gilead Sciences ( GILD ) and Merck ( MRK ) said Saturday that their phase 2 study evaluating the combination therapy of islatravir and lenacapavir as a potential treatment for HIV met its secondary endpoints. The combination therapy showed a 94% rate of viral suppression in the participants, the companies said. It was...
Copyright 2023-2026 - www.financetom.com All Rights Reserved